tert-Butyl 4-(3-chlorophenyl)-4-cyanopiperidine-1-carboxylate, 95%, 250mg

2-(2-Pyridyl)ethanesulfonic Acid>98.0%(HPLC)(T)5g

2-Methyl-1,3-benzoxazol-4-amine, 1g

(E)-3-(4-Chloro-3-fluorophenyl)acrylic acid, 95.0%, 25g

tert-Butyl (3-(hydroxymethyl)phenyl)carbamate, 97.0%, 25g

2-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole, 95.0%, 500g

7-methyl-1,4-dihydroquinolin-4-one, 97%, 5g

FMOC-4-TRIFLUOROMETHYL-D-PHENYLALANINE, 95%, 250mg

5-(2-Fluoro-phenyl)-furan-2-carboxylic acid, 1g

2-(Methylthio)oxazolo[4,5-b]pyridine, 95.0%, 5g

Plan stress-free PLPOLi 10x/0.25 IOS objective for iScope incident polarization, no cover glass correction. Working distance 10 mm

L-Theanine, 95.0%, 500g

1-(3-Butenyloxy)-2,3,3,4,4,5,5-heptafluorocyclopentene>97.0%(GC)1g